In this interview he mentions that they’re aiming for mid year turnarounds for both FDA approval of bronchitol and (if you listen closely) also partnership deal for LOXL2.
do not advertise external links.au/companies/stocktube/13328/pharmaxis-expects-an-fda-decision-on-bronchitol-mid-year-after-positive-committee-recommendation-13328.html
- Forums
- ASX - By Stock
- SNT
- Pharmaxis CEO present at Morgan
Pharmaxis CEO present at Morgan, page-16
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.002(4.55%) |
Mkt cap ! $54.92M |
Open | High | Low | Value | Volume |
4.4¢ | 5.0¢ | 4.4¢ | $137.0K | 2.933M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 152520 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 13000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 152520 | 0.045 |
1 | 100000 | 0.044 |
1 | 200000 | 0.043 |
5 | 1043537 | 0.041 |
5 | 588000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 13000 | 1 |
0.049 | 99999 | 1 |
0.050 | 146460 | 1 |
0.056 | 159576 | 1 |
0.058 | 41203 | 3 |
Last trade - 15.53pm 16/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |